Ke-Bin Huang

Ke-Bin Huang

Auto-generated profile, based on publicly available information

Ke-Bin Huang

Guangxi Normal University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2019 in Organic Letters
Verified
Journal Article
Closed access
MWMao-Rui Wang
Mao-Rui Wang
LDLi Deng
Li Deng
GLGuo-Chen Liu
Guo-Chen Liu
LWLing Wen
Ling Wen
JWJin-Ge Wang
Jin-Ge Wang
Ying-Ming PanYing-Ming Pan
Ying-Ming Pan

3 June 2022 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
XXXiaolin Xiong
Xiaolin Xiong
KHKe-Bin Huang
Ke-Bin Huang
YWYuan Wang
Yuan Wang
BCBei Cao
Bei Cao
YLYunli Luo
Yunli Luo
TZTaotao Zou
Taotao Zou

1 July 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
FWFeng-Yang Wang
Feng-Yang Wang
XTXiao-Ming Tang
Xiao-Ming Tang
XWXia Wang
Xia Wang
KHKe-Bin Huang
Ke-Bin Huang
HFHai-Wen Feng
Hai-Wen Feng
HLHong Liang
Hong Liang
Agents with multiple modes of tumor cell death can be effective chemotherapeutic drugs. One example of a bimodal chemotherapeutic approach is an agent that can induce both apoptosis and autophagic death. Thus far, no clinical anticancer drug has been shown to simultaneously induce both these pathways. Mono-functional platinum complexes are potent anticancer drug candidates which act through mechanisms distinct from cisplatin. Here, we describe the synthesis and characterize of two mono-functional platinum complexes containing 8-substituted quinoline derivatives as ligands, [PtL1Cl]Cl [L1 = (Z)-1-(pyridin-2-yl)-N-(quinolin-8-ylmethylene) methanamine] (Mon-Pt-1) and [PtL2Cl]Cl [L2 = (Z)-2-(pyridin-2-yl)-N-(quinolin-8-ylmethylene) ethanamine] (Mon-Pt-2). In comparison to cisplatin, Mon-Pt-2 exhibited a greater in vitro cytotoxicity, was more effective in resistant cells and elicited a better anticancer effect. Mechanistic experiments indicate that Mon-Pt-2 mainly accumulates in mitochondria, and stimulates significant TrxR inhibition ROS release and an ER stress response, mediated by mitochondrial dysfunction, ultimately resulting in a simultaneous induction of apoptosis and autophagy. Importantly, compared to cisplatin, Mon-Pt-2 exhibits lower acute toxicity and better anticancer activity in a murine tumor model. To the best of our knowledge, Mon-Pt-2 is the first mono-functional platinum complex inducing pro-death autophagy and apoptosis of cancer cells.

23 September 2019 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
KHKe-Bin Huang
Ke-Bin Huang
FWFeng-Yang Wang
Feng-Yang Wang
HFHai-Wen Feng
Hai-Wen Feng
HLHejiang Luo
Hejiang Luo
YLYan Long
Yan Long
HLHong Liang
Hong Liang
A platinum(II) complex containing an aminophosphonate ligand preferentially accumulates in the endoplamic reticulum (ER) in association with potent ER stress and reactive oxygen species generation, followed by the activation of damage-associated molecular pattern signals and immune responses. Importantly, the Pt complex exhibits potent anti-tumour activities in two independent mouse models via an immunogenic cell death pathway.

25 June 2024 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
YLYuan Lu
Yuan Lu
SWShan-Shan Wang
Shan-Shan Wang
MLMeng-Ya Li
Meng-Ya Li
RLRong Liu
Rong Liu
MZMeng-Fan Zhu
Meng-Fan Zhu
HLHong Liang
Hong Liang
The development of anticancer drugs to treat triple-negative breast cancer (TNBC) is an ongoing challenge. Immunogenic cell death (ICD) has garnered considerable interest worldwide as a promising synergistic modality for cancer chemoimmunotherapy. However, only few drugs or treatment modalities can trigger an ICD response and none of them exert a considerable clinical effect against TNBC. Therefore, new agents with potentially effective chemoimmunotherapeutic response are required. In this study, five new cyclometalated Ir(III) complexes containing isoquinoline alkaloid CˆN ligands were designed and synthesized. Among them, Ir-1 exhibited the highest in vitro cytotoxicity. Mechanistically, Ir-1 could trigger autophagy-dependent ferroptosis and a subsequent ferroptosis-dependent ICD response as well as indoleamine 2,3-dioxygenase (IDO) inhibition via reactive oxygen species (ROS)-mediated endoplasmic reticulum (ER) stress in MDA-MB-231 cells. When immunocompetent BALB/c mice were vaccinated with Ir-1-treated dying TNBC cells, antitumor CD8+ T-cell response and Foxp3+ T-cell depletion were induced, resulting in long-lasting antitumor immunity in TNBC cells. Moreover, combination therapy with Ir-1 and anti-PD1 could substantially augment in vivo therapeutic effects. Based on these results, Ir-1 is a promising candidate for chemoimmunotherapy against TNBC and its effects are mediated synergistically via ICD induction and IDO blockage.

25 April 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YLYuan Lu
Yuan Lu
FWFeng-Yang Wang
Feng-Yang Wang
MLMatthew S. Levine
Matthew S. Levine
HSHai-Rong Shi
Hai-Rong Shi
YWYuan Wang
Yuan Wang
KHKe-Bin Huang
Ke-Bin Huang